BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6928047)

  • 1. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
    Thompson EA; Moore WM; Sawyer RH
    J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
    Kaiser N; Milholland RJ; Rosen F
    Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
    Nicholson ML; Young DA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
    McPartland RP; Milholland RJ; Rosen F
    Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
    Chan AK; Thompson EA
    J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.
    Nicholson ML; Voris BP; Young DA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3530-7. PubMed ID: 6894886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
    Behrens UJ; Hollander VP
    Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
    Ip MM; Shea WK; Sykes D; Young DA
    Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
    Lucas KL; Barbour KW; Housley PR; Thompson EA
    Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.
    Stevens J; Stevens YW; Hollander VP
    Cancer Res; 1973 Feb; 33(2):370-4. PubMed ID: 4739450
    [No Abstract]   [Full Text] [Related]  

  • 13. Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.
    Nicholson ML; Young DA
    J Supramol Struct; 1979; 10(2):165-74. PubMed ID: 582325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
    Chi CW; Sykes D; Ip MM
    Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma.
    Chi CW; Ip MM
    J Natl Cancer Inst; 1988 Aug; 80(12):912-8. PubMed ID: 2456400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
    Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
    Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
    Wood KM; Thompson EA
    Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5551-6. PubMed ID: 1913674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid.
    Lui WY; Chi CW; Chang YF; Chu HW; Hsieh CC; Yin PH; Liu TY; Ou YR; P'eng FK
    Anticancer Res; 2002; 22(3):1413-22. PubMed ID: 12168818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
    Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.